Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Adverse Radiation Effects After Brain Metastases Radiosurgery
NCT02201563Phase 1Terminated
- Sponsor
- University of Pittsburgh
- Start
- Nov 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of minocycline in Acute Radiation Syndrome (ARS), sponsored by University of Pittsburgh. Primary endpoint: Monitoring for adverse effects of Minocycline at 3 months. Started Nov 2015; status: terminated.
02
Drugs
minocycline
03
Conditions
Acute Radiation Syndrome (ARS)
Beyond the preview
Go deeper on NCT02201563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201563.